Roivant Sciences ROIV
NASDAQ ROIV
$39.77 -0.21 (-0.53%)
At close: Sep 18, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Amortizatization of Intangibles (2021 - 2026)

Roivant Sciences' (ROIV) quarterly Amortizatization of Intangibles came in at $1.4 million in Q2 2026, down 28.26% on a YoY basis from $1.9 million in Q2 2025, and down 95.29% quarter-over-quarter from $29.6 million in Q4 2025.

Analysis

Roivant Sciences (ROIV) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends

Roivant Sciences (ROIV) has reported Amortizatization of Intangibles for 6 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Amortizatization of Intangibles fell 28.26% year-over-year to $1.4 million; the trailing twelve-month figure through Jun 2026 stood at $51.9 million (down 36.17% YoY), and the FY2026 full-year result was $8.3 million, up 20.94% from the prior year.
  • Amortizatization of Intangibles eased to $1.4 million in Q2 2026 per ROIV's latest filing, from $29.6 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $54.3 million in Q4 2024 and bottomed at $1.4 million in Q2 2026.
  • Historically, Amortizatization of Intangibles has averaged $11.5 million across 5 years, with a median of $2.2 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles surged 1282.96% in 2024, then sank 45.48% in 2025.
  • Over 5 years, Amortizatization of Intangibles stood at $6.0 million in 2022, then slipped by 16.01% to $5.0 million in 2023, then jumped by 975.97% to $54.3 million in 2024, then tumbled by 45.48% to $29.6 million in 2025, then sank by 95.29% to $1.4 million in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $1.4 million, $29.6 million, and $18.9 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn -
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 600.00 Mn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn -
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn -
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn -
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn 1.39 Mn
10 Insmed 26.19 Bn 25.03 Bn 358.27 Mn 678,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.39 Mn
Dec 31, 2025 29.61 Mn
Sep 30, 2025 18.94 Mn
Jun 30, 2025 1.94 Mn
Dec 31, 2024 54.30 Mn
Sep 30, 2024 23.46 Mn
Jun 30, 2024 1.58 Mn
Dec 31, 2023 5.05 Mn
Sep 30, 2023 1.70 Mn
Jun 30, 2023 1.62 Mn
Dec 31, 2022 6.01 Mn
Sep 30, 2022 2.19 Mn
Jun 30, 2022 2.00 Mn
Dec 31, 2021 5.40 Mn